ENOVIS CORP (ENOV) Stock News
NYSE:ENOV - New York Stock Exchange, Inc. - US1940141062 - Common Stock - Currency: USD
ENOV Latest News, Press Relases and Analysis
Enovis Corporation (ENOV): Among Billionaire Mason Hawkins’ Small-Cap Stocks with Huge Upside Potential
We recently published a list of Billionaire Mason Hawkins’ 10 Small-Cap Stocks with Huge Upside Potential. In this article, we are going to take a look at where Enovis Corporation (NYSE:ENOV) stands against other billionaire Mason Hawkins’ small-cap stocks with huge upside potential. Mason Hawkins’s Value Investment Strategy Mason Hawkins is a prominent American investor, […]
1 Unprofitable Stock with Competitive Advantages and 2 to Question
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.
Are Options Traders Betting on a Big Move in Enovis (ENOV) Stock?
Investors need to pay close attention to Enovis (ENOV) stock based on the movements in the options market lately.
Reasons to Sell ENOV and 1 Stock to Buy Instead
What a brutal six months it’s been for Enovis. The stock has dropped 22.5% and now trades at $31.96, rattling many shareholders. This might have investors contemplating their next move.
Mentions: TTD
Enovis to Host First Quarter 2025 Results Conference Call on May 8th
Wilimington, DE, April 17, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced...
Enovis to Host First Quarter 2025 Results Conference Call on May 8th
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer
Damien McDonald appointed CEO, effective as of May 12, 2025Company reiterates guidance for first quarter revenues and aEBITDA WIlmington. DE, April 02,...
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025
Alongside an evidence-based portfolio, Enovis will showcase how it’s “Redefining Every Step” with confidence-building education and a partnership that goes...
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025
Alongside an evidence-based portfolio, Enovis will showcase how it’s “Redefining Every Step” with confidence-building education and a partnership that goes beyond the product; attendees invited to exclusive events.
Enovis to Participate in Upcoming Investor Conferences
Wilmington, DE, March 05, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today...
Enovis to Participate in Upcoming Investor Conferences
Enovis Announces Fourth Quarter and Full Year 2024 Results
Continued commercial momentum with fourth-quarter sales growth of 23% on a reported basis and strong adjusted EBITDA margin expansion Fourth-quarter...
Enovis Announces Fourth Quarter and Full Year 2024 Results
Enovis Announces Planned CEO Succession Process
Wilmington, DE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), a leader in medical technology...
Enovis Announces Planned CEO Succession Process
Enovis (ENOV) Q4 Earnings: What To Expect
Medical technology company Enovis Corporation (NYSE:ENOV) will be announcing earnings results tomorrow before market open. Here’s what to expect.
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced...
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
Enovis™ Announces Leadership Change to International Surgical Business
Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently...
Enovis™ Announces Leadership Change to International Surgical Business
Instacart Grows Stronger: S&P MidCap 400 Inclusion, Ulta Partnership Boosts Stock
Instacart gains as it is set to join S&P MidCap 400. The company also partners with Ulta Beauty for same-day delivery, boosting stock value.
Instacart Stock Jumps. It'll Join The S&P MidCap 400 Index.
The grocery delivery company will soon join the S&P MidCap 400 index.